The recent genome-wide association study identified a link between vitiligo and genetic variants in the ribonuclease T2 (RNASET2) gene; however,the functional roles of RNASET2 in vitiligo pathogenesis or in melanocyte apoptosis have yet to be determined.The current study was designed to investigate the vitiligo-related expression pattern of RNASET2 and its molecular function involving apoptosis-related signaling proteins and pathways.The results showed overexpression of RNASET2 in epidermis specimens from 40 vitiligo patients compared to matched healthy controls.In addition,in vitro analyses indicated that overexpression of RNASET2 was inducible in cultured primary human melanocytes and keratinocytes by stress conditions,i.e,exposure to UV irradiation,hydrogen peroxide,and inflammatory factors,respectively and led to increased cell apoptosis via the tumor necrosis factor receptor-associated factor 2 (TRAF2)-caspases pathway through the physical interaction of RNASET2 with TRAF2.Thus,RNASET2 may contribute to vitiligo pathogenesis by inhibiting TRAF2 expression and,as such,RNASET2 may represent a potential therapeutic target of vitiligo.